Klazien Matter-Walstra

2PUBLICATIONS
0CO-AUTHORS
Econometric and statistical methodsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Nov 27, 2021
Handling Uncertainty in Cost-Effectiveness Analysis: Budget Impact and Risk Aversion.

Pedram Sendi, Klazien Matter-Walstra, Matthias Schwenkglenks

|Mar 22, 2017
Cost-effectiveness of palbociclib plus letrozole versus letrozole alone as a first-line treatment in women with oestrogen receptor-positive, HER2-negative, advanced breast cancer. Revised results for the Swiss health care setting.

K Matter-Walstra, M Schwenkglenks, K J Dedes

Pageof 1

Frequent Collaborators